{"id":"https://openalex.org/W2071246850","doi":"https://doi.org/10.1254/jphs.10050fp","title":"Pharmacological Characterization of Itch-Associated Response Induced by Repeated Application of Oxazolone in Mice","display_name":"Pharmacological Characterization of Itch-Associated Response Induced by Repeated Application of Oxazolone in Mice","publication_year":2010,"publication_date":"2010-01-01","ids":{"openalex":"https://openalex.org/W2071246850","doi":"https://doi.org/10.1254/jphs.10050fp","mag":"2071246850","pmid":"https://pubmed.ncbi.nlm.nih.gov/20595784"},"language":"en","primary_location":{"id":"doi:10.1254/jphs.10050fp","doi":"https://doi.org/10.1254/jphs.10050fp","is_oa":true,"landing_page_url":"https://doi.org/10.1254/jphs.10050fp","pdf_url":"https://www.jstage.jst.go.jp/article/jphs/113/3/113_10050FP/_pdf","source":{"id":"https://openalex.org/S163931769","display_name":"Journal of Pharmacological Sciences","issn_l":"1347-8613","issn":["1347-8613","1347-8648"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmacological Sciences","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://www.jstage.jst.go.jp/article/jphs/113/3/113_10050FP/_pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5075817564","display_name":"Yukihito Tsukumo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I205823427","display_name":"Kyowa Kirin (Japan)","ror":"https://ror.org/000wej815","country_code":"JP","type":"company","lineage":["https://openalex.org/I205823427"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Yukihito Tsukumo","raw_affiliation_strings":["Pharmacological Research Laboratories, Kyowa Hakko Kirin Co., Ltd., Nagaizumi-cho, Shizuoka, Japan. yukihito.tsukumo@kyowa-kirin.co.jp","Pharmacological Research Laboratories, Kyowa Hakko Kirin Co., Ltd., Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacological Research Laboratories, Kyowa Hakko Kirin Co., Ltd., Nagaizumi-cho, Shizuoka, Japan. yukihito.tsukumo@kyowa-kirin.co.jp","institution_ids":["https://openalex.org/I205823427"]},{"raw_affiliation_string":"Pharmacological Research Laboratories, Kyowa Hakko Kirin Co., Ltd., Japan","institution_ids":["https://openalex.org/I205823427"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5106407355","display_name":"Daisuke Harada","orcid":"https://orcid.org/0000-0003-1636-5365","observed_orcids":["https://orcid.org/0000-0003-1636-5365"]},"institutions":[{"id":"https://openalex.org/I205823427","display_name":"Kyowa Kirin (Japan)","ror":"https://ror.org/000wej815","country_code":"JP","type":"company","lineage":["https://openalex.org/I205823427"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Daisuke Harada","raw_affiliation_strings":["Pharmacological Research Laboratories, Kyowa Hakko Kirin Co., Ltd., Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacological Research Laboratories, Kyowa Hakko Kirin Co., Ltd., Japan","institution_ids":["https://openalex.org/I205823427"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111813219","display_name":"Haruhiko Manabe","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I205823427","display_name":"Kyowa Kirin (Japan)","ror":"https://ror.org/000wej815","country_code":"JP","type":"company","lineage":["https://openalex.org/I205823427"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"Haruhiko Manabe","raw_affiliation_strings":["Pharmacological Research Laboratories, Kyowa Hakko Kirin Co., Ltd., Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmacological Research Laboratories, Kyowa Hakko Kirin Co., Ltd., Japan","institution_ids":["https://openalex.org/I205823427"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I205823427"],"apc_list":{"value":2070,"currency":"USD","value_usd":2070},"apc_paid":null,"fwci":4.0315,"has_fulltext":true,"cited_by_count":35,"citation_normalized_percentile":{"value":0.93391241,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"113","issue":"3","first_page":"255","last_page":"262"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":0.9810000061988831,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":0.9810000061988831,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10196","display_name":"Pain Mechanisms and Treatments","score":0.007899999618530273,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11033","display_name":"Contact Dermatitis and Allergies","score":0.00139999995008111,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pruritus","display_name":"pruritus","score":0.8980000019073486},{"id":"https://openalex.org/keywords/oxazolone-induced-dermatitis","display_name":"oxazolone-induced dermatitis","score":0.8420000076293945},{"id":"https://openalex.org/keywords/chronic-dermatitis","display_name":"chronic dermatitis","score":0.7229999899864197},{"id":"https://openalex.org/keywords/scratching-behavior","display_name":"scratching behavior","score":0.9860000014305115},{"id":"https://openalex.org/keywords/leukotriene-b4-receptor","display_name":"leukotriene B4 receptor","score":0.9729999899864197},{"id":"https://openalex.org/keywords/muscarinic-m3-receptor","display_name":"M3 muscarinic receptor","score":0.9909999966621399},{"id":"https://openalex.org/keywords/naltrexone","display_name":"naltrexone","score":0.8330000042915344},{"id":"https://openalex.org/keywords/opioid-receptors","display_name":"opioid receptors","score":0.5109999775886536},{"id":"https://openalex.org/keywords/histamine-h1-receptor","display_name":"histamine H1 receptor","score":0.734000027179718},{"id":"https://openalex.org/keywords/5-ht2-receptor","display_name":"5-HT2 receptor","score":0.9020000100135803},{"id":"https://openalex.org/keywords/neurokinin-1-receptor","display_name":"neurokinin-1 receptor","score":0.7770000100135803},{"id":"https://openalex.org/keywords/cyclooxygenase","display_name":"cyclooxygenase","score":0.746999979019165},{"id":"https://openalex.org/keywords/platelet-activating-factor-receptor","display_name":"platelet-activating factor receptor","score":0.906000018119812},{"id":"https://openalex.org/keywords/5-lipoxygenase","display_name":"5-lipoxygenase","score":0.8510000109672546},{"id":"https://openalex.org/keywords/zileuton","display_name":"zileuton","score":0.8050000071525574},{"id":"https://openalex.org/keywords/montelukast","display_name":"montelukast","score":0.8569999933242798},{"id":"https://openalex.org/keywords/atropine","display_name":"atropine","score":0.7559999823570251},{"id":"https://openalex.org/keywords/darifenacin","display_name":"darifenacin","score":0.9800000190734863}],"concepts":[{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6671675443649292},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.6262873411178589},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.594498872756958},{"id":"https://openalex.org/C2779790080","wikidata":"https://www.wikidata.org/wiki/Q109353049","display_name":"Oxazolone","level":2,"score":0.546194314956665},{"id":"https://openalex.org/C2778122271","wikidata":"https://www.wikidata.org/wiki/Q410943","display_name":"Receptor antagonist","level":4,"score":0.5449418425559998},{"id":"https://openalex.org/C86811712","wikidata":"https://www.wikidata.org/wiki/Q410943","display_name":"Competitive antagonist","level":4,"score":0.4950810968875885},{"id":"https://openalex.org/C33789571","wikidata":"https://www.wikidata.org/wiki/Q410959","display_name":"Muscarinic acetylcholine receptor","level":3,"score":0.47763195633888245},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3767854571342468},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3367629051208496},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.2729058861732483},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.2592853307723999},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.07204508781433105}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000982","descriptor_name":"Antipruritics","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D000982","descriptor_name":"Antipruritics","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001522","descriptor_name":"Behavior, Animal","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D003876","descriptor_name":"Dermatitis, Atopic","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D003876","descriptor_name":"Dermatitis, Atopic","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D003876","descriptor_name":"Dermatitis, Atopic","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":true},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006241","descriptor_name":"Haptens","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D006241","descriptor_name":"Haptens","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008807","descriptor_name":"Mice, Inbred BALB C","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010081","descriptor_name":"Oxazolone","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D010081","descriptor_name":"Oxazolone","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D011537","descriptor_name":"Pruritus","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D011537","descriptor_name":"Pruritus","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D011537","descriptor_name":"Pruritus","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D011537","descriptor_name":"Pruritus","qualifier_ui":"Q000503","qualifier_name":"physiopathology","is_major_topic":true},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018102","descriptor_name":"Receptors, Leukotriene B4","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D018102","descriptor_name":"Receptors, Leukotriene B4","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D018727","descriptor_name":"Muscarinic Antagonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D018926","descriptor_name":"Anti-Allergic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D018926","descriptor_name":"Anti-Allergic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D020024","descriptor_name":"Leukotriene Antagonists","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D043587","descriptor_name":"Receptor, Muscarinic M3","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D043587","descriptor_name":"Receptor, Muscarinic M3","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":true},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1254/jphs.10050fp","doi":"https://doi.org/10.1254/jphs.10050fp","is_oa":true,"landing_page_url":"https://doi.org/10.1254/jphs.10050fp","pdf_url":"https://www.jstage.jst.go.jp/article/jphs/113/3/113_10050FP/_pdf","source":{"id":"https://openalex.org/S163931769","display_name":"Journal of Pharmacological Sciences","issn_l":"1347-8613","issn":["1347-8613","1347-8648"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmacological Sciences","raw_type":"journal-article"},{"id":"pmid:20595784","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/20595784","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of pharmacological sciences","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:531c59b6ee14424cb7bdad81e4cafb0c","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/531c59b6ee14424cb7bdad81e4cafb0c","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Journal of Pharmacological Sciences, Vol 113, Iss 3, Pp 255-262 (2010)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1254/jphs.10050fp","doi":"https://doi.org/10.1254/jphs.10050fp","is_oa":true,"landing_page_url":"https://doi.org/10.1254/jphs.10050fp","pdf_url":"https://www.jstage.jst.go.jp/article/jphs/113/3/113_10050FP/_pdf","source":{"id":"https://openalex.org/S163931769","display_name":"Journal of Pharmacological Sciences","issn_l":"1347-8613","issn":["1347-8613","1347-8648"],"is_oa":false,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-70"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmacological Sciences","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.8560000061988831,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2071246850.pdf","grobid_xml":"https://content.openalex.org/works/W2071246850.grobid-xml"},"referenced_works_count":42,"referenced_works":["https://openalex.org/W1495781935","https://openalex.org/W1896093603","https://openalex.org/W1915108447","https://openalex.org/W1963572696","https://openalex.org/W1966146079","https://openalex.org/W1968476184","https://openalex.org/W1978477650","https://openalex.org/W1983871703","https://openalex.org/W1988020407","https://openalex.org/W1995733311","https://openalex.org/W1996903618","https://openalex.org/W1997107703","https://openalex.org/W1998775865","https://openalex.org/W1999174354","https://openalex.org/W2000134341","https://openalex.org/W2000594231","https://openalex.org/W2017013284","https://openalex.org/W2024642221","https://openalex.org/W2027926428","https://openalex.org/W2030248217","https://openalex.org/W2034080984","https://openalex.org/W2034691182","https://openalex.org/W2036304017","https://openalex.org/W2063600274","https://openalex.org/W2065323160","https://openalex.org/W2069399018","https://openalex.org/W2069513027","https://openalex.org/W2070684661","https://openalex.org/W2073102792","https://openalex.org/W2080060643","https://openalex.org/W2083180420","https://openalex.org/W2084104871","https://openalex.org/W2094152116","https://openalex.org/W2108134012","https://openalex.org/W2114124504","https://openalex.org/W2125519865","https://openalex.org/W2125573904","https://openalex.org/W2144167082","https://openalex.org/W2152244488","https://openalex.org/W2166132450","https://openalex.org/W2416978698","https://openalex.org/W3158095185"],"related_works":["https://openalex.org/W2017176686","https://openalex.org/W1988020407","https://openalex.org/W2216083441","https://openalex.org/W1997073267","https://openalex.org/W2050098200","https://openalex.org/W2051277347","https://openalex.org/W2062077958","https://openalex.org/W2057268608","https://openalex.org/W2024642221","https://openalex.org/W2975335306"],"abstract_inverted_index":{"We":[0],"investigated":[1],"pharmacological":[2],"characteristics":[3],"of":[4,20,157],"the":[5,62,69,85,97,109,123,150],"itch-associated":[6,151],"response":[7,152],"to":[8,24,38],"chronic":[9,28],"dermatitis":[10,29],"induced":[11,153],"by":[12,61,68,96,108,120,154],"4-ethoxymethylene-2-phenyl-2-oxazolin-5-one":[13],"(oxazolone)":[14],"repeated":[15,155],"application":[16,156],"in":[17,149,159],"mice.":[18,160],"Application":[19],"an":[21],"oxazolone":[22,158],"challenge":[23],"mice":[25],"with":[26,122],"oxazolone-induced":[27],"evoked":[30],"severe":[31,54,91],"and":[32,42,55,101,129,142],"transient":[33],"scratching":[34,44,57,92,116],"behavior":[35,45,93,117],"for":[36,48],"up":[37],"1h.":[39],"Thereafter,":[40],"mild":[41],"continuous":[43,56,115],"was":[46,94,118],"observed":[47],"at":[49],"least":[50],"8":[51],"h.":[52],"Both":[53],"behaviors":[58],"were":[59],"suppressed":[60,95,119],"opioid-receptor":[63],"antagonist":[64,72,76,79,88,104,112,127,133],"naltrexone,":[65],"but":[66,106],"not":[67,107],"H(1)":[70],"histamine-receptor":[71],"fexofenadine,":[73],"5-hydroxytryptamine-2":[74],"(5-HT(2))-receptor":[75],"methysergide,":[77],"NK(1)-receptor":[78],"LY303870,":[80],"cyclooxygenase":[81],"inhibitor":[82,99],"indomethacin,":[83],"or":[84],"platelet-activating":[86],"factor-receptor":[87],"YM264.":[89],"The":[90,114],"5-lipoxygenase":[98],"zileuton":[100],"leukotriene":[102,139],"B(4)-receptor":[103],"ONO-4057,":[105],"cysteinyl":[110],"leukotriene-receptor":[111],"montelukast.":[113],"pretreatment":[121],"non-selective":[124],"muscarinic":[125,131,144],"acetylcholine-receptor":[126,132],"atropine":[128],"M(3)":[130,143],"darifenacin.":[134],"These":[135],"results":[136],"suggest":[137],"that":[138],"B(4)":[140],"receptor":[141,146],"acetylcholine":[145],"are":[147],"involved":[148]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":4},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":4},{"year":2015,"cited_by_count":2},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":4},{"year":2012,"cited_by_count":3}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}